Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance

Go back to Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
Abbott Laboratories (NYSE: ABT) Delayed: 98.39 -4.06 (3.96%)
Previous Close $102.45    52 Week High $46.38 
Open $101.31    52 Week Low $36.00 
Day High $106.35    P/E 65.59 
Day Low $97.67    EPS $1.50 
Volume 13,776,503